1706O Efficacy, safety and subgroup analysis of 177Lu-edotreotide vs everolimus in patients with grade 1 or grade 2 GEP-NETs: Phase III COMPETE trial

Jaume Capdevila, Holger Amthauer, C. Ansquer, E. Deshayes, R. Garcia-Carbonero, A. Teule, Hein J. Verberne, Jarosław B. Ćwikła, R. Sri Rajaskanthan, Chiara Maria Grana, Richard P. Baum, L.O. Dierickx, M. Michael, J. Strosberg, L. de Mestier du Bourg, Angelika Kluge, Stepan Melnyk, T. Walter